Literature DB >> 15249428

Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippocampal CA3 neurons from guinea-pigs.

Tobias Leniger1, Jan Thöne, Udo Bonnet, Andreas Hufnagel, Dieter Bingmann, Martin Wiemann.   

Abstract

The novel anticonvulsant levetiracetam (LEV) was tested for effects on bioelectric activity and intracellular pH (pHi) regulation of hippocampal CA3 neurons from adult guinea-pigs. In 4-aminopyridine-treated slices, LEV (10-100 microm) reduced the frequency of action potentials and epileptiform bursts of CA3 neurons by 30-55%, while the shape of these potentials remained largely unchanged. Suppressive effects were reversed by an increase of pHi with trimethylamine (TMA). Using BCECF-AM-loaded slices, we found that LEV (10-50 microm) reversibly lowered neuronal steady-state pHi by 0.19 +/- 0.07 pH units in the presence of extracellular CO2/HCO3- buffer. In the nominal absence of extracellular CO2/HCO3- or in Na+-free CO2/HCO3(-)-buffered solution, LEV had no effect on steady-state pHi. Recovery of pHi subsequent to ammonium prepulses remained unchanged in the absence of CO2/HCO3- buffer, but was significantly reduced by LEV in the presence of CO2/HCO3- buffer. These findings show that LEV inhibits HCO3(-)-dependent acid extrusion, but has no effect on Na+/H+ exchange. LEV did not affect Na+-independent Cl-/HCO3- exchange because intracellular alkalosis upon withdrawal of extracellular Cl- remained unchanged. These data show that LEV at clinically relevant concentrations inhibits Na+-dependent Cl-/HCO3- exchange, lowers neuronal pHi, and thereby may contribute to its anticonvulsive activity. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249428      PMCID: PMC1575181          DOI: 10.1038/sj.bjp.0705836

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Effect of levetiracetam on epileptiform discharges in human neocortical slices.

Authors:  Ali Gorji; Jorg-Michael Höhling; Michael Madeja; Heidrun Straub; Rüdiger Köhling; Ingrid Tuxhorn; Alois Ebner; Peter Wolf; H W Panneck; F Behne; Rainer Lahl; Erwin-Joseph Speckmann
Journal:  Epilepsia       Date:  2002-12       Impact factor: 5.864

2.  Regulation of Cl--HCO3- exchangers by cAMP-dependent protein kinase in adult rat hippocampal CA1 neurons.

Authors:  Christopher L Brett; Tony Kelly; Claire Sheldon; John Church
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

3.  Electrically evoked dendritic pH transients in rat cerebellar Purkinje cells.

Authors:  Debbie Willoughby; Christof J Schwiening
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

4.  Selective blockade of N-type calcium channels by levetiracetam.

Authors:  E A Lukyanetz; V M Shkryl; P G Kostyuk
Journal:  Epilepsia       Date:  2002-01       Impact factor: 5.864

5.  Levetiracetam opposes the action of GABAA antagonists in hypothalamic neurones.

Authors:  P Poulain; D G Margineanu
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

6.  Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?

Authors:  Michael Madeja; Doru Georg Margineanu; Ali Gorji; Elke Siep; Paul Boerrigter; Henrik Klitgaard; Erwin-Josef Speckmann
Journal:  Neuropharmacology       Date:  2003-10       Impact factor: 5.250

7.  Mechanisms underlying modulation of neuronal KCNQ2/KCNQ3 potassium channels by extracellular protons.

Authors:  David L Prole; Pedro A Lima; Neil V Marrion
Journal:  J Gen Physiol       Date:  2003-12       Impact factor: 4.086

8.  Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats.

Authors:  Doru Georg Margineanu; Henrik Klitgaard
Journal:  Eur J Pharmacol       Date:  2003-04-18       Impact factor: 4.432

9.  The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.

Authors:  J-M Rigo; G Hans; L Nguyen; V Rocher; S Belachew; B Malgrange; P Leprince; G Moonen; I Selak; A Matagne; H Klitgaard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slices.

Authors:  Isabelle Niespodziany; Henrik Klitgaard; Doru Georg Margineanu
Journal:  Neuroreport       Date:  2003-07-01       Impact factor: 1.837

View more
  10 in total

1.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

2.  Modulatory effects of neuropsychopharmaca on intracellular pH of hippocampal neurones in vitro.

Authors:  Udo Bonnet; Dieter Bingmann; Jens Wiltfang; Norbert Scherbaum; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

Review 3.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  Mice with a targeted disruption of the Cl-/HCO3- exchanger AE3 display a reduced seizure threshold.

Authors:  Moritz Hentschke; Martin Wiemann; Suna Hentschke; Ingo Kurth; Irm Hermans-Borgmeyer; Thomas Seidenbecher; Thomas J Jentsch; Andreas Gal; Christian A Hübner
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.

Authors:  Martin N Stienen; Aiden Haghikia; Hannes Dambach; Jan Thöne; Martin Wiemann; Ralf Gold; Andrew Chan; Rolf Dermietzel; Pedro M Faustmann; Daniel Hinkerohe; Nora Prochnow
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 6.  Levetiracetam Mechanisms of Action: From Molecules to Systems.

Authors:  Itzel Jatziri Contreras-García; Noemí Cárdenas-Rodríguez; Antonio Romo-Mancillas; Cindy Bandala; Sergio R Zamudio; Saúl Gómez-Manzo; Beatriz Hernández-Ochoa; Julieta Griselda Mendoza-Torreblanca; Luz Adriana Pichardo-Macías
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-13

7.  In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.

Authors:  Pierangelo Sardo; Stefania D'Agostino; Valerio Rizzo; Fabio Carletti; Gioacchino Lonobile; Giuseppe Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

8.  Disruption of Slc4a10 augments neuronal excitability and modulates synaptic short-term plasticity.

Authors:  Anne Sinning; Lutz Liebmann; Christian A Hübner
Journal:  Front Cell Neurosci       Date:  2015-06-16       Impact factor: 5.505

9.  Blockade of TASK-1 Channel Improves the Efficacy of Levetiracetam in Chronically Epileptic Rats.

Authors:  Ji-Eun Kim; Tae-Cheon Kang
Journal:  Biomedicines       Date:  2022-03-28

10.  A rise in saliva and urine pH in children with SCN1A-related epilepsy: An exploratory prospective controlled study.

Authors:  Qian Lu; Yang-Yang Wang; Hui-Min Chen; Qiu-Hong Wang; Xiao-Yan Yang; Li-Ping Zou
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.